Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
07/2006
07/20/2006CA2594654A1 N-((2z)-2-((4-hydroxyphenyl)imino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2
07/20/2006CA2594411A1 Peptidic biaryl antibacterial compounds comprising one or more basic amino acids
07/20/2006CA2594389A1 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006CA2594384A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/19/2006EP1680411A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
07/19/2006EP1680407A1 Isopentyl carboxanilides for combating undesired micro-organisms
07/19/2006EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/19/2006EP1492769B1 Novel process for the preparation of 1-phenyl-2-(2-pyridyl)ethanamine
07/19/2006EP1263740B1 Pyrimidine-4-one derivative as ldl-pla2 inhibitor
07/19/2006CN1805950A Method for preparing fused oxazinones
07/19/2006CN1805943A Alpha substituted carboxylic acid as PPAR modulators
07/19/2006CN1805937A N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine D3 receptor.
07/19/2006CN1805936A VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
07/19/2006CN1805930A Hydroxamic acids useful in the treatment of hyper-proliferative disorders
07/19/2006CN1805915A Indene derivatives as pharmaceutical agents
07/19/2006CN1803797A Inhibitors of dipeptidyl peptidase IV
07/19/2006CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists
07/19/2006CN1803793A Razole derivatives and application thereof
07/19/2006CN1803773A Synthesis and fine purification method of flunixin meglumine
07/19/2006CN1803772A Method for preparing 6-chloro-3-pyridinecarboxylic acid
07/19/2006CN1803760A N-arylation process with hydrazone as ligand in aqueous phase system
07/19/2006CN1264828C Nitric ester and nitrate salts of specific drugs
07/19/2006CN1264826C Process for preparing alcohol by heterocyclic carboxylic ester reduction
07/19/2006CN1264817C Certain cyclic thio substituted acylaminoacid amide derivatives
07/19/2006CN1264498C Primary intermediates for oxidative coloration of hair
07/18/2006USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals
07/18/2006US7078725 bis[2-(p-fluorophenyl)-5-trifluoromethylpyridine] complex of iridium(III) chloride carbonyl used to form the active layer in electronic devices
07/18/2006US7078552 Combretastatin A-1 phosphate and combretastatin B-1 phosphate prodrugs
07/18/2006US7078417 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
07/18/2006US7077872 Dyeing keratin fibers using developer ,coupler, oxidizer
07/18/2006CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/18/2006CA2351833C New cyclopropanic compounds, 1,1 and 1,2-disubstitute, their preparation process and pharmaceutical compositions containing them
07/18/2006CA2224528C Stilbene compositions in the adamantyl group, compositions containing them and uses
07/18/2006CA2190727C Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
07/13/2006WO2006074330A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
07/13/2006WO2006074244A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
07/13/2006WO2006073973A2 Novel benzylamine derivatives as cetp inhibitors
07/13/2006WO2006073361A1 Novel pyridine compounds
07/13/2006WO2006073112A1 Metal complex compound and organic electroluminescent element using the same
07/13/2006WO2006072775A2 Ionic liquids with a cation comprising a basic moiety
07/13/2006WO2006072596A1 6- (2 , 3 , 4 , 5-TETRAHYDRO-lH-BENZO [D] AZEPIN-7-YLOXY) -NICOTAMIDE DERIVATIVES AS RADIOLABELLED LIGANDS
07/13/2006WO2006072435A1 Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
07/13/2006WO2005112945A3 Synthesis of tetracyclines and analogues thereof
07/13/2006US20060155143 Producing purified trans-N-(4-isopropylcyclohexylcarbonyl)phenylalanineby reacting trans-4-isopropylcyclohexylcarbonyl chloride with phenylalanine in a mixed solvent of acetone and water keeping the pH >12.5 using potassium hydroxide; Schotten-Baumann reaction; industrialscale; cost efficiency
07/13/2006US20060155131 Forming a manganese oxide (MnO2)-based catalyst for making nicotinamides by reacting a manganous salt with potassium permanganate; use as intermediate to antituberculosis drugs i.e. isoniazid and as an intermediate of vitamin B12
07/13/2006US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria,
07/13/2006US20060154969 Adenosine receptor selective modulators
07/13/2006US20060154851 Pyridine derivates useful as fragrance materials
07/13/2006US20060154825 Novel crystalline modification of the anhydrate of boscalid
07/13/2006US20060154105 Nitrogenous heterocyclic derivative and organic elecrtroluminescent element employing the same
07/13/2006CA2605214A1 Benzylamine derivatives as cetp inhibitors
07/13/2006CA2594383A1 6- (2 , 3 , 4 , 5-tetrahydro-lh-benzo [d] azepin-7-yloxy) -nicotamide derivatives as radiolabelled ligands
07/13/2006CA2594255A1 Novel pyridine compounds
07/13/2006CA2594116A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
07/13/2006CA2594098A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
07/13/2006CA2593453A1 Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
07/12/2006EP1679313A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
07/12/2006EP1679296A1 Ether derivative
07/12/2006EP1678190A1 Metal complexes with bipodal ligands
07/12/2006EP1678167A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
07/12/2006EP1678161A2 Thioether-substituted benzamides as inhibitors of factor xa
07/12/2006EP1678154A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
07/12/2006EP1678149A2 4-amino(aza)quinoline derivatives as capsaicin receptor agonists
07/12/2006EP1678142A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
07/12/2006EP1678141A1 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
07/12/2006EP1678138A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
07/12/2006EP1678123A1 Tetrahydro-naphthalene and urea derivatives
07/12/2006EP1678121A2 Tao kinase modulators and methods of use
07/12/2006EP1677790A1 Alkynes ii
07/12/2006EP1677789A1 Alkynes i
07/12/2006EP1677788A1 Alkynes iii
07/12/2006EP1677745A2 Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders
07/12/2006EP1274685B1 A pyridine-n-oxide derivative, and process for its transformation into pharmaceutically effective compounds
07/12/2006EP1222163B1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
07/12/2006EP1103547B1 Formazan metal complex
07/12/2006EP1076648B1 Method for the catalytic production of substituted dipyridyl derivatives
07/12/2006CN1802379A Triazolopyrimidines
07/12/2006CN1802355A Aminoalcohol derivatives
07/12/2006CN1802154A Pyridine N-oxides as antiviral agents
07/12/2006CN1800178A Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof
07/12/2006CN1800174A Molecular switch crown ether-purple crystal quasirotaxane and its preparation method
07/12/2006CN1800163A Dissymmetrical diazo compounds comprising 2-pyridinium group and a cationic or non-cationic linker, compositions comprising them, method for coloring, and device
07/12/2006CN1800132A Arene olefin catalytic oxidation for preparing aromatic aldehyde
07/12/2006CN1263741C Preparation method of pyridine and 3-picoline
07/12/2006CN1263739C Carboxypeptidase U suppressed compound and its preparation method, pharmaceutical composition containing the compound and its uses
07/12/2006CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels
07/11/2006US7075102 cyclometalated complexes; organic light emitting devices
07/11/2006US7074952 Synthesis of taxol enhancers
07/11/2006US7074936 Analyzing hydrophobic proteins; laser desorption ionization spectroscopy
07/11/2006US7074934 Serine protease inhibitors
07/11/2006US7074929 Certain alkylene diamine-substituted heterocycles
07/11/2006US7074836 Para-terphenyl compounds
07/11/2006US7074813 Antiproliferation agent; antiumor, anticancer agents
07/11/2006US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders
07/11/2006US7074783 Analgesics; central nervous system disorders; asthma; rhinitis; antiarthritic agents; inflammatory bowel disorders
07/11/2006US7074780 Substituted phenylcyclohexanecarboxamides and their use
07/11/2006US7074742 Pyridinyl amides and imides for use as fungicides
07/11/2006US7074534 Polymeric charge transport compositions and electronic devices made with such compositions
07/11/2006US7074505 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
07/11/2006US7074504 Photoactive layer containing a lanthanide complex selected from [Ln( beta -enolate)3] bisphosphine oxide-sulfide)1 and Ln( beta -enolate)3(bisphosphine oxide-sulfide)2 derivatives